CHCI saw its Momentum Indicator move above the 0 level on October 28, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 105 similar instances where the indicator turned positive. In 83 of the 105 cases, the stock moved higher in the following days. The odds of a move higher are at 79%.
The Moving Average Convergence Divergence (MACD) for CHCI just turned positive on October 27, 2026. Looking at past instances where CHCI's MACD turned positive, the stock continued to rise in 30 of 39 cases over the following month. The odds of a continued upward trend are 77%.
Following a +8.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHCI advanced for three days, in 226 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The 10-day RSI Indicator for CHCI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 20 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 56%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
CHCI moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CHCI crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
CHCI broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CHCI entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CHCI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.356) is normal, around the industry mean (2.265). P/E Ratio (7.658) is within average values for comparable stocks, (53.132). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.683). Dividend Yield (0.000) settles around the average of (0.108) among similar stocks. P/S Ratio (2.764) is also within normal values, averaging (5.807).
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where REAX advanced for three days, in 213 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 69 cases where REAX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
REAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on REAX as a result. In 89 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The 50-day moving average for REAX moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where REAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for REAX entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.100) is normal, around the industry mean (2.265). P/E Ratio (-21.143) is within average values for comparable stocks, (53.132). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.683). Dividend Yield (0.000) settles around the average of (0.108) among similar stocks. P/S Ratio (0.192) is also within normal values, averaging (5.807).
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. REAX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
CHCI | REAX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 33 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 23 | 100 | |
SMR RATING 1..100 | 28 | 96 | |
PRICE GROWTH RATING 1..100 | 39 | 63 | |
P/E GROWTH RATING 1..100 | 76 | 18 | |
SEASONALITY SCORE 1..100 | 65 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
REAX's Valuation (6) in the null industry is somewhat better than the same rating for CHCI (69) in the Homebuilding industry. This means that REAX’s stock grew somewhat faster than CHCI’s over the last 12 months.
CHCI's Profit vs Risk Rating (23) in the Homebuilding industry is significantly better than the same rating for REAX (100) in the null industry. This means that CHCI’s stock grew significantly faster than REAX’s over the last 12 months.
CHCI's SMR Rating (28) in the Homebuilding industry is significantly better than the same rating for REAX (96) in the null industry. This means that CHCI’s stock grew significantly faster than REAX’s over the last 12 months.
CHCI's Price Growth Rating (39) in the Homebuilding industry is in the same range as REAX (63) in the null industry. This means that CHCI’s stock grew similarly to REAX’s over the last 12 months.
REAX's P/E Growth Rating (18) in the null industry is somewhat better than the same rating for CHCI (76) in the Homebuilding industry. This means that REAX’s stock grew somewhat faster than CHCI’s over the last 12 months.
| CHCI | REAX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 56% | N/A |
| Stochastic ODDS (%) | 2 days ago 65% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 79% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 77% | N/A |
| TrendWeek ODDS (%) | 2 days ago 70% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 69% | 2 days ago 88% |
| Advances ODDS (%) | 3 days ago 76% | 3 days ago 82% |
| Declines ODDS (%) | 16 days ago 67% | 8 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 75% | 2 days ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHCI’s FA Score shows that 2 FA rating(s) are green while REAX’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHCI’s TA Score shows that 3 TA indicator(s) are bullish while REAX’s TA Score has 3 bullish TA indicator(s).
CHCI (@Real Estate Development) experienced а -0.37% price change this week, while REAX (@Real Estate Development) price change was +2.42% for the same time period.
The average weekly price growth across all stocks in the @Real Estate Development industry was -0.09%. For the same industry, the average monthly price growth was -1.75%, and the average quarterly price growth was -14.80%.
CHCI is expected to report earnings on Nov 12, 2026.
REAX is expected to report earnings on Mar 12, 2027.
Activities range from the renovation and re-lease of existing buildings to the purchase of raw land and the sale of developed land or parcels to others. Demand for land development business is driven by GDP growth, employment rates, interest rates, and access to/cost of capital. For individual companies in this industry, proper cost estimation and successful bidding play critical roles in their profitability. Large companies could potentially have greater access to capital, while smaller companies can specialize in a specific geographic area or market niche. CBRE Group, VICI Properties Inc and Brookfield Property Partners L.P. are some of the large companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NFLT | 22.35 | 0.09 | +0.40% |
| Virtus Newfleet Multi-Sector Bond ETF (NFLT) | |||
| FEZ | 65.91 | -1.47 | -2.18% |
| State Street SPDR EURO STOXX 50 ETF (FEZ) | |||
| FDFF | 36.41 | -0.99 | -2.64% |
| Fidelity Disruptive Finance ETF (FDFF) | |||
| XHE | 95.91 | -3.60 | -3.62% |
| State Street SPDR S&P Health Care Equipment ETF (XHE) | |||
| EPSB | 25.82 | -1.12 | -4.14% |
| Harbor Smid Cap Core ETF | |||